Sisram Medical to Announce 2025 Annual Results on Monday, March 23, 2026
Earnings Conference Call to be Held on March 24, 2026 HONG KONG, March 12, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that it will report its audited consolidated results for...
ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
Conducting global licensing partnering of LMT15, a proprietary BBB Shuttle platform Also discussing global out-licensing of Phase 2 stage new drugs PF1801 and PF1804 SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a biopharmaceutical company developing treatments for rare diseases, announced that they will participate in...
Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China
Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater China SHANGHAI, March 12, 2026 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the Hong Kong Drug Office approved Ohtuvayre® (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in...
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and...
A THOUSAND PLUS CAMPAIGN #HOPENEEDSAHOME EARNS GLOBAL PRNEWS PURPOSE & IMPACT FUNDRAISING AWARD
'$1 is a Fortune in Africa' Platform Mobilizes Global Nutraceutical Industry to Secure Home for Nairobi Shelter Award Presented to The 6AM Agency for Global Fundraising Campaign Supporting Wings of Hope Fundraising Redefined to Rapid Impact Fundraising (RIF) Model with Low Entry, High Impact FRESNO, Calif., March 12, 2026 /PRNewswire/ -- A...
Building Resilient Rare Disease Support in Malaysia with Pharm-D Health Science’s VALENS Specialised Nutrition
KUALA LUMPUR, Malaysia, March 12, 2026 /PRNewswire/ -- As Malaysia commemorates National Rare Disease Day and marks the launch of the National Policy for Rare Diseases, long-term, sustainable care for individuals living with rare, complex genetic conditions is now gaining growing attention and interest from across public and private stakeholders. Among the critical components of long-term care for certain...
Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office
New Tokyo office strengthens local partnerships, regulatory alignment and global integrations in the world's third largest pharmaceutical market BETHESDA, Md., March 12, 2026 /PRNewswire/ -- Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development, has announced the opening of its new Japan office, deepening its commitment to the Asia-Pacific...
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
SINGAPORE, March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories ("Charles River"), a global contract research organization (CRO) providing drug development support and biologics testing solutions, have signed a Memorandum of Understanding (MoU) during the APAC Biomanufacturing Leadership Summit...
Sky Labs Launches their support of the American Heart Association’s ‘Established Investigator Award for Clinical Hypertension’
SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- Sky Labs announced on 12th that it is supporting the Established Investigator Award for Clinical Hypertension' developed by the American Heart Association (the Association). This support follows a Memorandum of Understanding (MoU) signed with the Association last September. It is expected to significantly support...
LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility
WUXI, China, March 12, 2026 /PRNewswire/ -- LabConnect, a leading provider of technology-driven central laboratory services and functional service provider solutions for clinical trials, today announced the grand opening of its new facility in Wuxi, China. As clinical trials become increasingly global and complex, sponsors are seeking laboratory partners that can provide...
